In adults with tetralogy of Fallot, increasing right atrial pressure predicted cardiovascular adverse events (HR 1.28 per 5 mm Hg; 95% CI 1.10-1.47; P=0.028).
Cohort (n=225)
No
Does right atrial pressure predict disease severity and cardiovascular adverse events in adults with tetralogy of Fallot?
In symptomatic adults with tetralogy of Fallot, elevated right atrial pressure correlates with disease severity and predicts future cardiovascular adverse events.
Effect estimate: HR 1.28 (95% CI 1.10-1.47)
p-value: p=0.028
Background Right atrial pressure ( RAP ), a composite metric of right ventricular diastolic function, volume status, and right heart compliance, is a predictor of mortality in patients with heart failure due to acquired heart disease. Because patients with tetralogy of Fallot ( TOF ) might have abnormal right atrial and ventricular mechanics caused by myocardial injury and remodeling, we hypothesized that RAP would be associated with disease severity and cardiovascular adverse events in this population. Methods and Results We performed a cohort study of adults with TOF who underwent right heart catheterization at the Mayo Clinic Rochester between 1990 and 2017. The objective was to determine the association between RAP and multiple domains of disease severity in TOF (percentage of predicted peak oxygen consumption, atrial or ventricular arrhythmia, and heart failure hospitalization), as well as cardiovascular adverse events, defined as sustained ventricular tachycardia, resuscitated or aborted sudden death, heart transplantation, or death. Among 225 patients (113 male; mean age: 39±14 years), mean RAP was 10.7±5.2 mm Hg and median was 10 mm Hg (interquartile range: 7–13 mm Hg). Increasing RAP was associated with atrial or ventricular arrhythmias (odds ratio: 5.01; 95% CI, 1.22–23.49; P <0.001), heart failure hospitalization (odds ratio: 1.47; 95% CI, 1.10–2.39; P =0.033) per 5 mm Hg, and worsening exercise capacity (peak oxygen consumption; R 2 =0.74, r =−0.86, P <0.001). RAP was a predictor of cardiovascular adverse events (hazard ratio: 1.28; 95% CI, 1.10–1.47; P =0.028) per 5 mm Hg. Conclusions In symptomatic patients with TOF , increasing RAP correlates with multiple domains of disease severity (risk stratification) and predicts future cardiovascular events (prognostication). These data have potential clinical implications in the target population of symptomatic TOF patients.
Egbe et al. (Fri,) conducted a cohort in Tetralogy of Fallot (n=225). Right atrial pressure was evaluated on Cardiovascular adverse events (sustained ventricular tachycardia, resuscitated or aborted sudden death, heart transplantation, or death) (HR 1.28, 95% CI 1.10-1.47, p=0.028). In adults with tetralogy of Fallot, increasing right atrial pressure predicted cardiovascular adverse events (HR 1.28 per 5 mm Hg; 95% CI 1.10-1.47; P=0.028).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: